Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced the publication of a supplemental update to its £10 billion Euro Medium Term Note Programme, reflecting the latest information for investors and guaranteeing the notes through the company. The update, which is crucial for stakeholders, is now available on Haleon’s website for review. Haleon, listed on both the LSE and NYSE, is known for its leading consumer health products, including well-known brands like Advil, Sensodyne, and Centrum.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
